GG

Ganpatdas Gokuldas Ranka

Active Director Director DIN 08198200
DIN 08198200 First appointment Aug 2018 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Ganpatdas Gokuldas Ranka

Data last updated:

Ganpatdas Gokuldas Ranka is a Director at Rokdia Pharma Private Limited (since 2018). The company operates in Business Services.

DIN 08198200
Primary Designation Director
Industry Business Services
First Appointment 10 Aug 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rokdia Pharma Private Limited U74999PN2018PTC178122
Director10 Aug 20182018Active

Board colleagues of Ganpatdas Gokuldas Ranka

NameDINCompanyDesignation
Swati Sunil Jaybhaye08198201Rokdia Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Rokdia Pharma Private Limited
Premium access

Shareholding and investment profile for Ganpatdas Gokuldas Ranka

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ganpatdas Gokuldas Ranka

Ganpatdas Gokuldas Ranka currently holds 1 directorship: Rokdia Pharma Private Limited (Director, since 10 Aug 2018).

Ganpatdas Gokuldas Ranka was first appointed on 10 Aug 2018 as Director at Rokdia Pharma Private Limited.

The current boards of Ganpatdas Gokuldas Ranka's companies include Swati Sunil Jaybhaye (Rokdia Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available